Literature DB >> 11868638

Transfusion practices for elective orthopedic surgery.

Brian G Feagan1, Cindy J Wong, William C Johnston, Ramiro Arellano, Nigel Colterjohn, Keyvan Karkouti, Kim Turner.   

Abstract

BACKGROUND: Use of blood conservation techniques in elective surgery reduces the risk of infection and transfusion reactions that result from using allogeneic blood products. We examined the transfusion practice and blood conservation strategies for elective orthopedic procedures in 19 Canadian hospitals.
METHODS: We reviewed the medical records of patients who underwent total hip or knee joint arthroplasty between June 1998 and January 1999 in a convenience sample of 19 hospitals to determine the pre- and postoperative hemoglobin concentrations, concurrent medical conditions, participation status in an autologous blood donation program, use of other blood conservation techniques, and occurrence of allogeneic and autologous transfusions. Patients were considered eligible for autologous blood donation if they weighed at least 25 kg, were in good general health without major cardiac conditions and had a hemoglobin concentration of at least 110 g/L.
RESULTS: We reviewed 4535 medical records. Of the 4422 patients whose eligibility status was known, 2561 (57.9%) were eligible to participate in an autologous blood donation program. Only 842 (18.6%) of the patients predonated blood. Patients who did not predonate blood were older (mean age 70.1 v. 63.8 years) and were more likely to have concomitant medical conditions (60.3% v. 37.9%) than those who did predonate. Overall, 30.6% (95% confidence interval [CI] 29.1%-32.1%) of the patients who did not predonate blood received allogeneic transfusions. For patients who predonated, the rate of allogeneic transfusion was 14.1% (95% CI 11.8%-16.5%). The frequency with which blood conservation techniques other than autologous blood donation were used was minimal (in 2.4% of all cases).
INTERPRETATION: The use of blood conservation techniques among hospitals in Canada remains low. Only a minority of eligible patients participated in an autologous blood donation program.

Entities:  

Mesh:

Year:  2002        PMID: 11868638      PMCID: PMC99309     

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  17 in total

Review 1.  Rheumatology: 10. Joint replacement of the hip and knee--when to refer and what to expect.

Authors:  O H Brady; B A Masri; D S Garbuz; C P Duncan
Journal:  CMAJ       Date:  2000-11-14       Impact factor: 8.262

2.  Testing of individual blood donations for HCV RNA reduces the residual risk of transfusion-transmitted HCV infection.

Authors:  T J Legler; J Riggert; G Simson; C Wolf; A Humpe; U Munzel; A Uy; M Köhler; K H Heermann
Journal:  Transfusion       Date:  2000-10       Impact factor: 3.157

3.  Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.

Authors:  B G Feagan; C J Wong; A Kirkley; D W Johnston; F C Smith; P Whitsitt; S L Wheeler; C Y Lau
Journal:  Ann Intern Med       Date:  2000-12-05       Impact factor: 25.391

4.  Aprotinin decreases exposure to allogeneic blood during primary unilateral total hip replacement.

Authors:  J M Murkin; G M Haig; K J Beer; N Cicutti; J McCutchen; M E Comunale; R Hall; B B Ruzicka
Journal:  J Bone Joint Surg Am       Date:  2000-05       Impact factor: 5.284

5.  Increases in serum concentrations of cardiac proteins and the prediction of early postoperative cardiovascular complications in noncardiac surgery patients.

Authors:  F Neill; J W Sear; G French; H Lam; M Kemp; R J Hooper; P Foex
Journal:  Anaesthesia       Date:  2000-07       Impact factor: 6.955

6.  Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. The Rizzoli Study Group on Orthopaedic Anaesthesia.

Authors:  B Borghi; A Casati
Journal:  Eur J Anaesthesiol       Date:  2000-07       Impact factor: 4.330

7.  Transfusion-related sepsis due to Serratia liquefaciens in the United States.

Authors:  V R Roth; M J Arduino; J Nobiletti; S C Holt; L A Carson; C F Wolf; B A Lenes; P M Allison; W R Jarvis
Journal:  Transfusion       Date:  2000-08       Impact factor: 3.157

8.  Perceptions and preferences of autologous blood donors.

Authors:  S J Lee; B Liljas; W H Churchill; M A Popovsky; C P Stowell; M E Cannon; M Johannesson
Journal:  Transfusion       Date:  1998-08       Impact factor: 3.157

9.  Perioperative myocardial ischemic episodes are related to hematocrit level in patients undergoing radical prostatectomy.

Authors:  C W Hogue; L T Goodnough; T G Monk
Journal:  Transfusion       Date:  1998-10       Impact factor: 3.157

Review 10.  Acute normovolemic hemodilution.

Authors:  T G Monk; L T Goodnough
Journal:  Clin Orthop Relat Res       Date:  1998-12       Impact factor: 4.176

View more
  7 in total

1.  Reducing the risk of allogeneic blood transfusion.

Authors:  Battista Borghi; Hanna van Oven
Journal:  CMAJ       Date:  2002-02-05       Impact factor: 8.262

Review 2.  Laboratory characteristics and clinical utility of post-operative cell salvage: washed or unwashed blood transfusion?

Authors:  Manuel Muñoz; Robert Slappendel; Dafydd Thomas
Journal:  Blood Transfus       Date:  2010-09-14       Impact factor: 3.443

3.  Preoperative autologous blood donation in lower limb arthroplasty surgery: has the time come for its retirement?

Authors:  Manuel Muñoz; José A García-Erce
Journal:  Blood Transfus       Date:  2013-05-07       Impact factor: 3.443

4.  Spanish Consensus Statement on alternatives to allogeneic blood transfusion: the 2013 update of the "Seville Document".

Authors:  Santiago R Leal-Noval; Manuel Muñoz; Marisol Asuero; Enric Contreras; José A García-Erce; Juan V Llau; Victoria Moral; José A Páramo; Manuel Quintana
Journal:  Blood Transfus       Date:  2013-06-17       Impact factor: 3.443

5.  Blood transfusion practices: a little consistency please.

Authors:  Mark T Friedman
Journal:  Blood Transfus       Date:  2011-05-12       Impact factor: 3.443

6.  Determinants of allogeneic transfusion among patients who had an autologous blood procedure, France.

Authors:  Simone Mathoulin-Pélissier; Louis Rachid Salmi; Charlotte Huët
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

7.  Blood transfusion practices in total joint arthroplasties in Jamaica.

Authors:  Re Christopher Rose; Ayana Crichlow; Christine Walters; Andrew Ameerally; Georgiana Gordon-Strachan
Journal:  J Clin Med Res       Date:  2009-12-28
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.